Adding Morphine to ESP Block in Management of Acute PMP

Launched by ASSIUT UNIVERSITY · Dec 16, 2023

Keywords

ClinConnect Summary

This clinical trial is looking into how well adding morphine helps relieve pain after a modified radical mastectomy, a type of surgery for breast cancer. Specifically, researchers want to see if giving morphine in two different amounts (3 mg and 5 mg) alongside a specific type of pain relief called an erector spinae plane block can make a difference in managing acute pain following the surgery.

To participate in this study, women aged 18 to 60 who are undergoing this surgery may be eligible, as long as they are in good health (classified as ASA I or II, which refers to their overall physical condition). However, those with certain health issues, allergies to the study medications, or infections at the injection site won't be able to take part. If you join the trial, you can expect to receive either morphine or a placebo (a treatment with no active medicine) along with standard pain management, while doctors monitor your recovery and pain levels. This study is still in the planning stages and has not started recruiting participants yet.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1/female patients aged from 18 to 60 years.
• • 2/ASA I -II
• • 3/Surgery is modified radical mastectomy
• Exclusion Criteria:
• • 1/ASA more than II
• • 2/Patients with known allergy to study drugs
• • 3/Skin infection at site of needle puncture
• • 4/Coagulopathy
• • 5/Uncooperative patients